173 related articles for article (PubMed ID: 31806933)
1. Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells.
Liu Z; Yu M; Fei B; Sun J; Wang D
Drug Des Devel Ther; 2019; 13():3823-3834. PubMed ID: 31806933
[TBL] [Abstract][Full Text] [Related]
2. Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer.
Liu Z; Yu M; Fei B; Sun J; Wang D
Onco Targets Ther; 2019; 12():2095-2104. PubMed ID: 30936724
[TBL] [Abstract][Full Text] [Related]
3. XLF-mediated NHEJ activity in hepatocellular carcinoma therapy resistance.
Yang S; Wang XQ
BMC Cancer; 2017 May; 17(1):344. PubMed ID: 28526069
[TBL] [Abstract][Full Text] [Related]
4. XLF/Cernunnos: An important but puzzling participant in the nonhomologous end joining DNA repair pathway.
Menon V; Povirk LF
DNA Repair (Amst); 2017 Oct; 58():29-37. PubMed ID: 28846869
[TBL] [Abstract][Full Text] [Related]
5. ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells.
Narayan S; Ramisetti S; Jaiswal AS; Law BK; Singh-Pillay A; Singh P; Amin S; Sharma AK
Eur J Med Chem; 2019 Jan; 161():456-467. PubMed ID: 30384048
[TBL] [Abstract][Full Text] [Related]
6. Absence of XRCC4 and its paralogs in human cells reveal differences in outcomes for DNA repair and V(D)J recombination.
Ruis B; Molan A; Takasugi T; Hendrickson EA
DNA Repair (Amst); 2020 Jan; 85():102738. PubMed ID: 31731258
[TBL] [Abstract][Full Text] [Related]
7. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells.
Wen C; Chen J; Zhang D; Wang H; Che J; Qin Q; He L; Cai Z; Lin M; Lou Q; Huang L; Chen D; Iwamoto A; Ren D; Wang L; Lan P; Wang J; Liu H; Yang X
Cancer Lett; 2016 Dec; 383(2):295-308. PubMed ID: 27713084
[TBL] [Abstract][Full Text] [Related]
8. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
9. Interplay between Cernunnos-XLF and nonhomologous end-joining proteins at DNA ends in the cell.
Wu PY; Frit P; Malivert L; Revy P; Biard D; Salles B; Calsou P
J Biol Chem; 2007 Nov; 282(44):31937-43. PubMed ID: 17720816
[TBL] [Abstract][Full Text] [Related]
10. Genetic interaction between DNA repair factors PAXX, XLF, XRCC4 and DNA-PKcs in human cells.
Xing M; Oksenych V
FEBS Open Bio; 2019 Jul; 9(7):1315-1326. PubMed ID: 31141305
[TBL] [Abstract][Full Text] [Related]
11. PAXX and XLF DNA repair factors are functionally redundant in joining DNA breaks in a G1-arrested progenitor B-cell line.
Kumar V; Alt FW; Frock RL
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10619-24. PubMed ID: 27601633
[TBL] [Abstract][Full Text] [Related]
12. PAXX is a novel target to overcome resistance to doxorubicin and cisplatin in osteosarcoma.
Ma W; Yang L; Liu H; Chen P; Ren H; Ren P
Biochem Biophys Res Commun; 2020 Jan; 521(1):204-211. PubMed ID: 31640855
[TBL] [Abstract][Full Text] [Related]
13. Live cell imaging of XLF and XRCC4 reveals a novel view of protein assembly in the non-homologous end-joining pathway.
Yano K; Chen DJ
Cell Cycle; 2008 May; 7(10):1321-5. PubMed ID: 18418068
[TBL] [Abstract][Full Text] [Related]
14. XRCC4 and XLF form long helical protein filaments suitable for DNA end protection and alignment to facilitate DNA double strand break repair.
Mahaney BL; Hammel M; Meek K; Tainer JA; Lees-Miller SP
Biochem Cell Biol; 2013 Feb; 91(1):31-41. PubMed ID: 23442139
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of sphingosine-1-phosphate receptor 2 antagonists as potent 5-FU-resistance reversal agents for the treatment of colorectal cancer.
Luo D; Zhang Y; Yang S; Tian X; Lv Y; Guo Z; Liu X; Han G; Liu S; Wang W; Cui S; Qu X; Wan S
Eur J Med Chem; 2021 Dec; 225():113775. PubMed ID: 34411894
[TBL] [Abstract][Full Text] [Related]
16. XRCC4/XLF Interaction Is Variably Required for DNA Repair and Is Not Required for Ligase IV Stimulation.
Roy S; de Melo AJ; Xu Y; Tadi SK; Négrel A; Hendrickson E; Modesti M; Meek K
Mol Cell Biol; 2015 Sep; 35(17):3017-28. PubMed ID: 26100018
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of XLF and PAXX prevents DNA double-strand break repair by non-homologous end joining in lymphocytes.
Hung PJ; Chen BR; George R; Liberman C; Morales AJ; Colon-Ortiz P; Tyler JK; Sleckman BP; Bredemeyer AL
Cell Cycle; 2017 Feb; 16(3):286-295. PubMed ID: 27830975
[TBL] [Abstract][Full Text] [Related]
18. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
19. DNA-PK and ATM phosphorylation sites in XLF/Cernunnos are not required for repair of DNA double strand breaks.
Yu Y; Mahaney BL; Yano K; Ye R; Fang S; Douglas P; Chen DJ; Lees-Miller SP
DNA Repair (Amst); 2008 Oct; 7(10):1680-92. PubMed ID: 18644470
[TBL] [Abstract][Full Text] [Related]
20. Cernunnos/XLF: a new player in DNA double-strand break repair.
Yano K; Morotomi-Yano K; Akiyama H
Int J Biochem Cell Biol; 2009 Jun; 41(6):1237-40. PubMed ID: 18992362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
